These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
82 related articles for article (PubMed ID: 7434566)
21. Protection against influenza virus infection in BALB/c mice immunized with a single dose of neuraminidase-expressing DNAs by electroporation. Chen J; Fang F; Li X; Chang H; Chen Z Vaccine; 2005 Jul; 23(34):4322-8. PubMed ID: 15925433 [TBL] [Abstract][Full Text] [Related]
22. The effect of sodium fluoride on experimental influenza virus infection in mice. Prahoveanu E; Eşanu V Virologie; 1981; 32(4):293-5. PubMed ID: 7331235 [TBL] [Abstract][Full Text] [Related]
23. Oral administration of heat-killed Lactobacillus plantarum L-137 enhances protection against influenza virus infection by stimulation of type I interferon production in mice. Maeda N; Nakamura R; Hirose Y; Murosaki S; Yamamoto Y; Kase T; Yoshikai Y Int Immunopharmacol; 2009 Aug; 9(9):1122-5. PubMed ID: 19410659 [TBL] [Abstract][Full Text] [Related]
24. Protection from lethal influenza virus challenge by oral type 1 interferon. Beilharz MW; Cummins JM; Bennett AL Biochem Biophys Res Commun; 2007 Apr; 355(3):740-4. PubMed ID: 17316562 [TBL] [Abstract][Full Text] [Related]
25. Identification of effective constituents of influenza vaccine by immunization with plasmid DNAs encoding viral proteins. Ze C; Kurata T; Tamura S Jpn J Infect Dis; 2000 Dec; 53(6):219-28. PubMed ID: 11227019 [TBL] [Abstract][Full Text] [Related]
26. MDCK cell-cultured influenza virus vaccine protects mice from lethal challenge with different influenza viruses. Liu K; Yao Z; Zhang L; Li J; Xing L; Wang X Appl Microbiol Biotechnol; 2012 Jun; 94(5):1173-9. PubMed ID: 22415544 [TBL] [Abstract][Full Text] [Related]
27. Cross-protection of mice immunized with different influenza A (H2) strains and challenged with viruses of the same HA subtype. Govorkova EA; Smirnov YuA Acta Virol; 1997 Oct; 41(5):251-7. PubMed ID: 9607078 [TBL] [Abstract][Full Text] [Related]
28. [Effect of aspirin and indocin on the course of influenza virus infection in mice]. Denys A; Pokrzeptowicz-Gawryszewsk Med Dosw Mikrobiol; 1970; 22(2):169-74. PubMed ID: 5428966 [No Abstract] [Full Text] [Related]
30. Heterologous protection of mice from a lethal human H1N1 influenza A virus infection by H3N8 equine defective interfering virus: comparison of defective RNA sequences isolated from the DI inoculum and mouse lung. Duhaut SD; Dimmock NJ Virology; 1998 Sep; 248(2):241-53. PubMed ID: 9721233 [TBL] [Abstract][Full Text] [Related]
31. Response of ferrets to infection with a live attenuated influenza virus and to subsequent heterologous challenge. Delem A Dev Biol Stand; 1976; 33():226-33. PubMed ID: 955269 [TBL] [Abstract][Full Text] [Related]
32. Anti-viral immunity induced by recombinant nucleoprotein of influenza A virus. II. Protection from influenza infection and mechanism of protection. Tite JP; Hughes-Jenkins C; O'Callaghan D; Dougan G; Russell SM; Gao XM; Liew FY Immunology; 1990 Oct; 71(2):202-7. PubMed ID: 2172156 [TBL] [Abstract][Full Text] [Related]
33. Immunization with influenza A NP-expressing vaccinia virus recombinant protects mice against experimental infection with human and avian influenza viruses. Altstein AD; Gitelman AK; Smirnov YA; Piskareva LM; Zakharova LG; Pashvykina GV; Shmarov MM; Zhirnov OP; Varich NP; Ilyinskii PO; Shneider AM Arch Virol; 2006 May; 151(5):921-31. PubMed ID: 16292596 [TBL] [Abstract][Full Text] [Related]
34. Effect of 60amino-6-deoxy-D-glucose hydrochloride on influenza infection in mice. Hrusková J; Jarý J; Danes L; Jelínková A; Novák M Acta Virol; 1975 Jan; 19(1):47-51. PubMed ID: 235197 [TBL] [Abstract][Full Text] [Related]
35. Cross-reactive neuraminidase antibodies afford partial protection against H5N1 in mice and are present in unexposed humans. Sandbulte MR; Jimenez GS; Boon AC; Smith LR; Treanor JJ; Webby RJ PLoS Med; 2007 Feb; 4(2):e59. PubMed ID: 17298168 [TBL] [Abstract][Full Text] [Related]
36. [The protector effect of ribosomal preparations against experimental influenza infection in mice]. Popa LM; Repanovici R; Iliescu R Virologie; 1989; 40(1):65-70. PubMed ID: 2549704 [TBL] [Abstract][Full Text] [Related]
37. [The protective effect of human and cow milk mucoids in experimental influenza virus infection of the mouse]. Schmidt E; Janssen M Z Kinderheilkd; 1967; 98(4):307-14. PubMed ID: 6031965 [No Abstract] [Full Text] [Related]
38. Poly(gamma-glutamic acid) nano-particles combined with mucosal influenza virus hemagglutinin vaccine protects against influenza virus infection in mice. Okamoto S; Matsuura M; Akagi T; Akashi M; Tanimoto T; Ishikawa T; Takahashi M; Yamanishi K; Mori Y Vaccine; 2009 Sep; 27(42):5896-905. PubMed ID: 19647814 [TBL] [Abstract][Full Text] [Related]
39. In vivo anti-influenza virus activity of Kampo (Japanese herbal) medicine "Sho-seiryu-to"--effects on aged mice, against subtypes of a viruses and B virus, and therapeutic effect. Nagai T; Urata M; Yamada H Immunopharmacol Immunotoxicol; 1996 May; 18(2):193-208. PubMed ID: 8771367 [TBL] [Abstract][Full Text] [Related]
40. Muramyl peptides and polyinosinic-polycytodylic acid given to mice prior to influenza virus challenge reduces pulmonary disease and mortality. Wyde PR; Six HR; Ambrose MW; Throop BJ J Biol Response Mod; 1990 Feb; 9(1):98-102. PubMed ID: 2319263 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]